According to this new report, the global atrial fibrillation market is estimated to be valued at US$ 16 Billion in the year 2028, growing at a CAGR of 11.5% in the period 2021 to 2028. Growth of the market is driven by the prevalence of atrial fibrillation cases and cardiac disorders, a rise in the number of hypertension patients, growth in the geriatric population, and increasing demand for minimally invasive procedures.
Atrial fibrillation (AF) is a type of cardiac arrhythmia characterized by irregular electrical activities in the atria. It is the most common form of cardiac arrhythmia. The condition is classified into three categories: paroxysmal, persistent, and permanent atrial fibrillation. Treatment of AF is dependent on the duration and severity of the underlying symptoms.
Technological advancement in cardiac imaging has led to substantial enhancement of the efficacy of atrial fibrillation ablation. Advanced cardiac imaging is expected to bring about improved catheter AF ablation outcomes by risk stratification and early detection of cerebral emboli with pre-procedural use of 3D printed models.
Segments Covered
The report provides revenue forecasts for global, regional, and country levels. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. For the purpose of research, the publisher has segmented the global atrial fibrillation market reports on the basis of geography and market segments.
Device Type Outlook
End-User Outlook
Regional Outlook
Country Outlook
Vendors Outlook
Target Audience